Abstract
1265P Toripalimab plus chemotherapy as neoadjuvant treatment for resectable stage IIB-IIIB NSCLC (RENAISSANCE study): A single-arm, phase II trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have